Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.
about
Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphaeDelaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortalityCandida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansSurface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative mediumThe trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.A novel pseudopodial component of the dendritic cell anti-fungal response: the fungipodSystems Biology Approaches for Host-Fungal Interactions: An Expanding Multi-Omics FrontierAntifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug actionEfficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosisEfficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosisInhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus speciesPotent synergism of the combination of fluconazole and cyclosporine in Candida albicansIn vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environmentDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsAntimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999In vitro activity of a new pneumocandin antifungal agent, L-733,560 against azole-susceptible and -resistant Candida and Torulopsis speciesComparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assaysIn vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida speciesAspergillus fumigatus and aspergillosisCell wall mannan and cell surface hydrophobicity in Candida albicans serotype A and B strains.Potential use of BacT/Alert automated blood culture system for antifungal susceptibility testing.New and emerging yeast pathogensChronic urinary tract infection due to Candida utilis.Candida biofilms: an update.Human endothelial cells internalize Candida parapsilosis via N-WASP-mediated endocytosisInclusion complex of a new propiconazole derivative with β-cyclodextrin: NMR, ESI-MS and preliminary pharmacological studies.Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT studyIn vitro activity of caspofungin against Candida albicans biofilms.Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene.Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo.Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature.Dispersion as an important step in the Candida albicans biofilm developmental cycle.The ins and outs of DNA fingerprinting the infectious fungiFluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.Sodium chloride treatment of amphotericin B nephrotoxicity. Standard of care?Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes.
P2860
Q24290929-F805F23C-EBF0-4842-9409-92AEE8D692CDQ24530412-2B9A4493-1B29-4B7F-B875-5B035C81C6E7Q24550731-E3B0790D-8ED6-4F4E-BA89-561BC9F71B1BQ24625384-2F79A755-F886-49CA-8581-1FF85022E58EQ24630977-F2D54049-41EA-4667-BB69-79F66148E315Q24814052-9482F537-EAE8-4F90-91A3-1CD484C06C64Q25257510-D41C16D7-564D-4044-8F38-79CE79B9E41CQ27315931-841CA20A-E3FF-4A98-9C5C-A09856C10109Q28068488-12D88A4B-30F3-421B-B8FC-264C42640907Q28343624-75F60AAB-0ED9-4F1C-9A72-0313D9901819Q28343919-C5C8A8E1-C55E-4A43-A82A-C57DE4813EBDQ28343922-32545577-948B-4878-BA70-5BB9529BF365Q28343924-D7BEB766-46A8-4235-8F1F-3F21C66D97EAQ28344597-FB1B351C-7431-4634-A18E-26208AB7DD3DQ28345161-089D3C36-BF7A-4785-AB13-73FD076A853DQ28362118-187DB724-0631-455C-9788-ABE8B7BA167AQ28362691-73B51F16-E41B-42A4-90E6-E34E75E46D2CQ28366760-F63FFBCC-54B8-457E-8B3F-924AE982B17AQ28378793-A2C1B33B-19C2-4815-99F2-EDFC4C14CD59Q28378998-3F92B192-8AA3-478B-881D-4A30ED7BC201Q28379025-DD583F96-AB79-4FF4-8772-458CBAA790A2Q29617908-55A17312-8DB7-42BC-8025-35EDF4A92949Q30434895-B12584FD-D905-4374-99A4-EBF2A43242D4Q30451507-A1DB0ACF-7259-4CAB-B474-A892163B6E6EQ30452880-6B73F703-4D38-4329-83DA-F2FCB64CAD5EQ30453823-341B1B52-05C6-410F-A6E6-3CF0080CB34BQ30475833-A29E7F45-324B-4A16-AC8B-C2689295AD84Q30541724-BBDF4F38-3076-4754-8D47-1FB642652547Q30907922-732F5C68-C214-4EB9-BF08-351FE354A6AEQ31054881-A68A7BF8-C02A-4B7C-AE54-8C6D4D5BC319Q31114513-7B4D7331-85AE-410C-ACE9-E1F6AE33F29BQ32065060-0358D6E9-707C-4B48-9FD7-C044DF47BC6AQ33250085-93D10D3F-365E-44E0-B89A-874F92B80ECAQ33540545-C9B8A3BD-C7FF-4174-AF3A-97B14430A541Q33548720-71D43721-FA6A-460A-9D16-F47214DE8602Q33555593-60B8EBBA-3F6B-43BB-A9EB-829E518F078BQ33593689-D7A995A7-9831-4BFB-A5E6-EF210008A8B9Q33608492-8E773200-9B2E-422C-BD7D-E90BE0D6759DQ33613758-C5C83B4B-BA04-4B9D-B534-D921744B7044Q33655898-A59E73A5-D2FF-4E31-8746-6082C6102BBB
P2860
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Secular trends in the epidemio ...... nfections Surveillance System.
@en
Secular trends in the epidemio ...... nfections Surveillance System.
@nl
type
label
Secular trends in the epidemio ...... nfections Surveillance System.
@en
Secular trends in the epidemio ...... nfections Surveillance System.
@nl
prefLabel
Secular trends in the epidemio ...... nfections Surveillance System.
@en
Secular trends in the epidemio ...... nfections Surveillance System.
@nl
P356
P1476
Secular trends in the epidemio ...... Infections Surveillance System
@en
P2093
C Beck-Sagué
W R Jarvis
P304
P356
10.1093/INFDIS/167.5.1247
P407
P577
1993-05-01T00:00:00Z